The positive reaction in Sutro Biopharma's stock price can be attributed to the market's favorable reception of the company's financial performance for FY23. Financial results often play a critical role in influencing investor sentiment and stock prices, especially when they exceed market expectations. In this case, the announcement likely signaled to investors that Sutro Biopharma is on a solid financial footing, leading to increased demand for its shares.